Prosecution Insights
Last updated: April 19, 2026

Tsubota Laboratory, Inc.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
4
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18561634 OPHTHALMIC PREPARATION FOR MYOPIA SUPPRESSION VAJDA, KRISTIN ANN 1622 Non-Final OA Nov 16, 2023
18266103 Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral Thinning RZECZYCKI, PHILLIP MATTHEW 1625 Non-Final OA Jun 08, 2023
18266102 Eyedrops for Inhibiting Myopia Progression in Children and Screening Method for Inhibitor of Myopia Progression in Children BELL, SARA ELIZABETH 1625 Non-Final OA Jun 08, 2023
18253155 Agent for Adjusting Hardness of Lens of Eye MILLER, DALE R 1693 Final Rejection May 16, 2023
18246508 PROPHYLACTIC AGENT, AMELIORATING AGENT, AND THERAPEUTIC AGENT FOR DRY EYE BARHAM, BETHANY P 1611 Final Rejection Mar 23, 2023
18026232 DEVICE AND METHOD FOR INHIBITING CHOROIDAL THINNING EISEMAN, LYNSEY C 3796 Final Rejection Mar 14, 2023
16982152 NON-INVASIVE CORNEA AND SCLERA STRENGTHENING DEVICE AND METHOD ALLEN, ROBERT F 3783 Final Rejection Sep 18, 2020

Managing Tsubota Laboratory, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month